The Technical Analyst
Select Language :
Danaher Corp [DAP.DE]

Exchange: XETRA Industry: Health Care Equipment & Services

Danaher Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Danaher Corp is listed at the  Exchange

0.43% €231.75

Europe/Berlin / 2 mai 2024 @ 15:16


FUNDAMENTALS
MarketCap: 171 654 mill
EPS: 5.08
P/E: 45.62
Earnings Date: Jul 22, 2024
SharesOutstanding: 740.69 mill
Avg Daily Volume: 0.0005 mill
RATING 2024-05-02
A+
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Neutral
Return On Asset: Buy
DE: Buy
P/E: Strong Buy
Price To Book: Buy
QUARTER GROWTHS
4/221/232/233/234/231/24
Revenue
Gr.Profit
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
2.50x
Company: PE 45.62 | sector: PE 18.22
PE RATIO: COMPANY / INDUSTRY
1.53x
Company: PE 45.62 | industry: PE 29.80
DISCOUNTED CASH FLOW VALUE
€139.50
(-39.81%) €-92.25
Date: 2024-05-02
Expected Trading Range (DAY)

€ 227.88 - 235.62

( +/- 1.67%)
ATR Model: 14 days

Live Trading Signals (every 1 min)

Forecast 1: 15:26 - €232.59
Forecast 2: 16:00 - €231.75
Forecast 3: 16:00 - €231.75
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
Volume Signals
Price €231.75 (0.43% )
Volume 0.0003 mill
Avg. Vol. 0.0005 mill
% of Avg. Vol 57.14 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Danaher Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Danaher Corp

RSI

Last 10 Buy & Sell Signals For DAP.DE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Danaher Corp

DAP.DE

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

Last 10 Buy Signals

Date Signal @
SCNSOLUSDMay 2 - 09:51162.60
VOW.OLMay 2 - 09:38NOK6.80
NICEMay 2 - 09:51$218.25
SALME.OLMay 2 - 09:367.28
^IBEXMay 2 - 09:36PTS10 877
INVUSDMay 2 - 09:5041.75
ILMNMay 2 - 09:48$122.50
LSG.OLMay 2 - 09:33NOK48.56
EXASMay 2 - 09:47$59.23
DOGEUSDMay 2 - 09:47$0.130

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.